Metraipolis › archive › dc_8eb028f4f7c8
Safety of immune checkpoint inhibitors for cancer treatment: real-world retrospective data analysis from Qatar (SAFE-ICI-Q study) — Europe PMC PMID:41235221
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41235221
- DOI
- 10.3389/fimmu.2025.1665716
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T23:30:09.558Z
- SHA-256 of the archived text
7c2d50060aee5f02b62768de0a1921a3a1f430f73fc0e1be5c6b0520e713fdfb- Stable URL of this page
https://metraipolis.com/documento/dc_8eb028f4f7c8
How to cite
Safety of immune checkpoint inhibitors for cancer treatment: real-world retrospective data analysis from Qatar (SAFE-ICI-Q study) — Europe PMC PMID:41235221 — Europe PMC (en), https://europepmc.org/article/MED/41235221 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8eb028f4f7c8 (Metraipolis archive dc_8eb028f4f7c8, sha256 7c2d50060aee5f02b62768de0a1921a3a1f430f73fc0e1be5c6b0520e713fdfb)
BibTeX
@misc{dc8eb028f4f7c8,
title = {Safety of immune checkpoint inhibitors for cancer treatment: real-world retrospective data analysis from Qatar (SAFE-ICI-Q study) — Europe PMC PMID:41235221},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41235221},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8eb028f4f7c8; sha256 7c2d50060aee5f02b62768de0a1921a3a1f430f73fc0e1be5c6b0520e713fdfb},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41235221. Agents can read the archived copy with the MCP tool read_document.